| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | COLLEGIUM PHARMACEUTICAL INC COM | 1,887,332 | 29,386,000 | 36.98% | ||
| 2 | Lion Biotechnologies | 2,188,331 | 15,209,000 | 19.14% | ||
| 3 | CIDARA THERAPEUTICS INC | 1,312,258 | 13,647,000 | 17.18% | ||
| 4 | AMICUS THERAPEUTICS INC | 2,600,014 | 12,922,000 | 16.26% | ||
| 5 | IGNYTA INC COM | 950,366 | 5,037,000 | 6.34% | ||
| 6 | ProNAi Therapeutics, Inc. | 2,186,195 | 3,257,000 | 4.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001420506-17-000146, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
